Wolfe Research Upgrades CVS Health (CVS) to Outperform 'on Stars/Potential for More Realistic LT Guide Setting Up Attractive Risk/Reward'
Tweet Send to a Friend
Wolfe Research analyst Justin Lake upgraded CVS Health (NYSE: CVS) from Peerperform to Outperform with a price target of $80.00.The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
